Skip to main content
. 2019 Oct 30;2019:4602371. doi: 10.1155/2019/4602371

Figure 3.

Figure 3

Overall survival outcomes based on ACVR2B-AS1 expression levels in different subgroups. Notes: The subgroups include tumor grades G1/G2, G3/G4, stage I/II, stage III/IV, males, females, and younger and older patients.